menu
    • menu

    Company profile for Raziel Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into thermogenic, brown-like adipose tissue. Raziel’s prime-candidate, RZL-012, is a first-in-class, currently in clinical development to treat obesity and related disorders. Raziel launched its clinical trial in the US at Q4 2015, expectin...
    Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into thermogenic, brown-like adipose tissue. Raziel’s prime-candidate, RZL-012, is a first-in-class, currently in clinical development to treat obesity and related disorders. Raziel launched its clinical trial in the US at Q4 2015, expecting final data that include safety and efficacy, by mid of 2016.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Raziel TherapeuticsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Hi-Tech Park, Edmond J. Safra Campus, Givat-Ram, Jerusalem P.O. Box 39135, Jer...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://raziel-therapy.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    365mc, Raziel Therapeutics Speed Up RZL-012 Development in Korea
    365mc, Raziel Therapeutics Speed Up RZL-012 Development in Korea

    15 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/365mc-and-raziel-therapeutics-announce-strategic-collaboration-to-accelerate-development-of-rzl-012-in-south-korea-302505353.html

    PR NEWSWIRE
    15 Jul 2025
    Share Share
    Raziel, Fosun Start Ph3 China Trial For Submental Fat Reduction
    Raziel, Fosun Start Ph3 China Trial For Submental Fat Reduction

    03 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/raziel-and-fosun-pharma-by-juvestar-an-affiliate-company-of-fosun-pharma-initiate-phase-3-registration-trial-in-china-for-submental-fat-reduction-double-chin-302389946.html

    PR NEWSWIRE
    03 Mar 2025
    Share Share
    Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012 
    Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012 

    17 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/raziel-announces-china-market-license-agreement-with-fosun-pharma-for-rzl-012-301133135.html#:~:text=REHOVOT%2C%20Israel%2C%20Sept.%2017,to%20%2474%20million%2C%20based%20on

    PRNEWSWIRE
    17 Sep 2020
    Share Share
    Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012
    Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012

    16 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/raziel-announces-china-market-license-agreement-with-fosun-pharma-for-rzl-012-301133135.html

    PRNEWSWIRE
    16 Sep 2020
    Share Share
    Fat Melting Pharmaceutical Company Raziel Raises $22 Million in Series C
    Fat Melting Pharmaceutical Company Raziel Raises $22 Million in Series C

    18 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fat-melting-pharmaceutical-company-raziel-therapeutics-raises-22-million-in-series-c-funding-round-300976823.html

    PR NEWSWIRE
    18 Dec 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search